147 related articles for article (PubMed ID: 16376831)
1. Practical proteomic biomarker discovery: taking a step back to leap forward.
Listgarten J; Emili A
Drug Discov Today; 2005 Dec; 10(23-24):1697-702. PubMed ID: 16376831
[TBL] [Abstract][Full Text] [Related]
2. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
Phan JH; Quo CF; Wang MD
Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
[TBL] [Abstract][Full Text] [Related]
3. The clinical application of proteomics.
Colantonio DA; Chan DW
Clin Chim Acta; 2005 Jul; 357(2):151-8. PubMed ID: 15896729
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in atherosclerosis-based proteomics: new biomarkers and a future perspective.
Alvarez-Llamas G; de la Cuesta F; Barderas ME; Darde V; Padial LR; Vivanco F
Expert Rev Proteomics; 2008 Oct; 5(5):679-91. PubMed ID: 18937558
[TBL] [Abstract][Full Text] [Related]
5. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
Jurisicova A; Jurisica I; Kislinger T
Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
[TBL] [Abstract][Full Text] [Related]
6. Interpretation of large-scale quantitative shotgun proteomic profiles for biomarker discovery.
Isserlin R; Emili A
Curr Opin Mol Ther; 2008 Jun; 10(3):231-42. PubMed ID: 18535930
[TBL] [Abstract][Full Text] [Related]
7. Analytical considerations for mass spectrometry profiling in serum biomarker discovery.
Whiteley GR; Colantonio S; Sacconi A; Saul RG
Clin Lab Med; 2009 Mar; 29(1):57-69. PubMed ID: 19389551
[TBL] [Abstract][Full Text] [Related]
8. Difference detection in LC-MS data for protein biomarker discovery.
Listgarten J; Neal RM; Roweis ST; Wong P; Emili A
Bioinformatics; 2007 Jan; 23(2):e198-204. PubMed ID: 17237092
[TBL] [Abstract][Full Text] [Related]
9. Biomarker assay translation from discovery to clinical studies in cancer drug development: quantification of emerging protein biomarkers.
Lee JW; Figeys D; Vasilescu J
Adv Cancer Res; 2007; 96():269-98. PubMed ID: 17161683
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics: the promises and challenges of mass spectrometry-based biomarker discovery.
deVera IE; Katz JE; Agus DB
Clin Adv Hematol Oncol; 2006 Jul; 4(7):541-9. PubMed ID: 17147241
[TBL] [Abstract][Full Text] [Related]
11. Advanced proteomic technologies for cancer biomarker discovery.
Wong SC; Chan CM; Ma BB; Lam MY; Choi GC; Au TC; Chan AS; Chan AT
Expert Rev Proteomics; 2009 Apr; 6(2):123-34. PubMed ID: 19385940
[TBL] [Abstract][Full Text] [Related]
12. Proteomic methods for biomarker discovery in urine.
Wilkey DW; Merchant ML
Semin Nephrol; 2007 Nov; 27(6):584-96. PubMed ID: 18061841
[TBL] [Abstract][Full Text] [Related]
13. Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.
Good DM; Thongboonkerd V; Novak J; Bascands JL; Schanstra JP; Coon JJ; Dominiczak A; Mischak H
J Proteome Res; 2007 Dec; 6(12):4549-55. PubMed ID: 17970587
[TBL] [Abstract][Full Text] [Related]
14. Role and challenges of proteomics in pharma and biotech: technical, scientific and commercial perspective.
Qoronfleh MW
Expert Rev Proteomics; 2006 Apr; 3(2):179-95. PubMed ID: 16608432
[TBL] [Abstract][Full Text] [Related]
15. Mass spectrometry: uncovering the cancer proteome for diagnostics.
van der Merwe DE; Oikonomopoulou K; Marshall J; Diamandis EP
Adv Cancer Res; 2007; 96():23-50. PubMed ID: 17161675
[TBL] [Abstract][Full Text] [Related]
16. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
17. Practical points in urinary proteomics.
Thongboonkerd V
J Proteome Res; 2007 Oct; 6(10):3881-90. PubMed ID: 17824635
[TBL] [Abstract][Full Text] [Related]
18. Translation of neurological biomarkers to clinically relevant platforms.
Hayes RL; Robinson G; Muller U; Wang KK
Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
[TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
20. Approaches to dimensionality reduction in proteomic biomarker studies.
Hilario M; Kalousis A
Brief Bioinform; 2008 Mar; 9(2):102-18. PubMed ID: 18310106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
